Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-Sectional, Observational Study of the Prevalence of Adenoviral-Specific Antibodies and Inflammatory Cytokines in Participants With Chronic Granulomatous Disease

NCT06605378 is registered in ClinicalTrials.gov with Ensoma as lead sponsor.

NCT NCT06605378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06605378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-Sectional, Observational Study of the Prevalence of Adenoviral-Specific Antibodies and Inflammatory Cytokines in Participants With Chronic Granulomatous Disease
Lead sponsor
Ensoma
Phase
Observational
Overall status
Recruiting
Start date
November 18, 2024
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

chronic granulomatous disease (cgd)